These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

925 related items for PubMed ID: 19307067

  • 1. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
    Lin CC, Hsu CH, Cheng JC, Huang CY, Tsai YC, Hsu FM, Huang KH, Cheng AL, Pu YS.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):442-8. PubMed ID: 19307067
    [Abstract] [Full Text] [Related]

  • 2. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT, Arcangeli G, Cruciani E, Altavista P, Mecozzi A, Saracino B, Orefici F.
    Cancer; 2004 Dec 01; 101(11):2540-8. PubMed ID: 15481058
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 4. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL, Shipley WU, Kaufman DS, Zehr EM, Heney NM, Althausen AF, McGovern FJ.
    J Urol; 1998 Nov 01; 160(5):1673-7. PubMed ID: 9783929
    [Abstract] [Full Text] [Related]

  • 5. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.
    Arch Esp Urol; 1997 Jun 01; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [Abstract] [Full Text] [Related]

  • 6. Can patient selection for bladder preservation be based on response to chemotherapy?
    Sternberg CN, Pansadoro V, Calabrò F, Schnetzer S, Giannarelli D, Emiliozzi P, De Paula F, Scarpone P, De Carli P, Pizzo M, Platania A, Amini M.
    Cancer; 2003 Apr 01; 97(7):1644-52. PubMed ID: 12655521
    [Abstract] [Full Text] [Related]

  • 7. Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer.
    Weiss C, Engehausen DG, Krause FS, Papadopoulos T, Dunst J, Sauer R, Rödel C.
    Int J Radiat Oncol Biol Phys; 2007 Jul 15; 68(4):1072-80. PubMed ID: 17467193
    [Abstract] [Full Text] [Related]

  • 8. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
    Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M, Jones J, Balcerzak SP, Crawford ED, Grossman HB.
    J Urol; 2001 Jan 15; 165(1):56-60; discussion 60-1. PubMed ID: 11125363
    [Abstract] [Full Text] [Related]

  • 9. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H.
    Cancer; 1998 Mar 01; 82(5):918-22. PubMed ID: 9486582
    [Abstract] [Full Text] [Related]

  • 10. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 11. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS, Winter KA, Shipley WU, Heney NM, Wallace HJ, Toonkel LM, Zietman AL, Tanguay S, Sandler HM.
    Urology; 2009 Apr 01; 73(4):833-7. PubMed ID: 19100600
    [Abstract] [Full Text] [Related]

  • 12. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M, Miyanaga N, Tokuuye K, Saida Y, Ohara K, Sugahara S, Kagei K, Igaki H, Hashimoto T, Hattori K, Shimazui T, Akaza H, Akine Y.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1371-9. PubMed ID: 16580495
    [Abstract] [Full Text] [Related]

  • 13. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
    Koga F, Yoshida S, Kawakami S, Kageyama Y, Yokoyama M, Saito K, Fujii Y, Kobayashi T, Kihara K.
    Urology; 2008 Aug 01; 72(2):384-8. PubMed ID: 18455771
    [Abstract] [Full Text] [Related]

  • 14. Organ-sparing treatment in muscle-invasive bladder cancer.
    Dunst J, Diestelhorst A, Kühn R, Müller AC, Scholz HJ, Fornara P.
    Strahlenther Onkol; 2005 Oct 01; 181(10):632-7. PubMed ID: 16220401
    [Abstract] [Full Text] [Related]

  • 15. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
    Chauvet B, Brewer Y, Félix-Faure C, Davin JL, Choquenet C, Reboul F.
    J Urol; 1996 Oct 01; 156(4):1258-62. PubMed ID: 8808849
    [Abstract] [Full Text] [Related]

  • 16. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report.
    Henry LR, Goldberg M, Scott W, Konski A, Meropol NJ, Freedman G, Weiner LM, Watts P, Beard M, McLaughlin S, Cheng JD.
    Ann Surg Oncol; 2006 Feb 01; 13(2):214-20. PubMed ID: 16418887
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study].
    Chauvet B, Félix-Faure C, Davin JL, Berger C, Vincent P, Reboul F.
    Cancer Radiother; 1998 Apr 01; 2 Suppl 1():77s-81s. PubMed ID: 9749084
    [Abstract] [Full Text] [Related]

  • 18. A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement.
    Chiang Y, Cheng JC, Huang CY, Tsai YC, Lin CC, Hsu CH, Cheng AL, Pu YS.
    J Formos Med Assoc; 2017 Sep 01; 116(9):689-696. PubMed ID: 28034491
    [Abstract] [Full Text] [Related]

  • 19. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
    Koga F, Kihara K, Fujii Y, Yoshida S, Saito K, Masuda H, Kageyama Y, Kawakami S.
    BJU Int; 2009 Jul 01; 104(2):189-94. PubMed ID: 19154452
    [Abstract] [Full Text] [Related]

  • 20. Radical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle.
    Arias F, Dueñas M, Martínez E, Domínguez MA, Illarramendi JJ, Villafranca E, Tejedor M, Molina F, Meiriño R, Valerdi JJ.
    Cancer; 1997 Jul 01; 80(1):115-20. PubMed ID: 9210716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.